HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Elizabeth Arden And Del Labs Open Door To First Nail Care Collaboration

This article was originally published in The Rose Sheet

Executive Summary

Elizabeth Arden Red Door Nail Care collection includes lacquers formulated with bioactive glass and UV protection to maintain color that lasts up to seven days, according to licensee Del Labs

You may also be interested in...



Marketing In Brief

Del Labs/Arden partnership: Del Labs will introduce nail care products under the Elizabeth Arden and Red Door brands through a trademark licensing agreement with Arden, firm announces. Products will be available later this year in prestige salons and spas nationwide, including Elizabeth Arden and Red Door spa locations. Agreement marks Del Labs' foray into the professional nail care category. Company currently offers mass market nail care products under the Sally Hansen brand and is the number one manufacturer in the channel, according to Del Labs...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013218

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel